Skip to main navigation Skip to main content
info(at)avldigital.remove-this.de
Deutsch English
Last searches

Results for *

Displaying results 1 to 9 of 9.

  1. De materia medica
    Author: Dioscorides, Pedanius
    Published: 2017
    Publisher:  Olms-Weidmann, Hildesheim

    Export to reference management software   RIS file
      BibTeX file
    Content information
    Source: Union catalogues
    Contributor: Beck, Lily Y. (Übersetzer)
    Language: English
    Media type: Book
    Format: Print
    ISBN: 9783487155715; 3487155710
    Other identifier:
    9783487155715
    Edition: Third, revised edition
    Series: Altertumswissenschaftliche Texte und Studien ; Band 38
    Subjects: Pharmakologie; Arzneimittel; Pharmakologie; Pharmazie
    Other subjects: Dioscorides, Pedanius (40-90): De materia medica; (Produktform)Paperback / softback; Biologie; Botanik; Gesundheit; Heilpflanzen; Pflanzenkunde; (VLB-WN)1567: Hardcover, Softcover / Sprachwissenschaft, Literaturwissenschaft/Klassische Sprachwissenschaft, Literaturwissenschaft
    Scope: XXVIII, 608 Seiten, 21 cm, 896 Gramm
  2. Sharing RD risk in healthcare via FDA hedges
    Author: Jørring, Adam; Lo, Andrew W.; Philipson, Tomas J.; Singh, Manita; Thakor, Richard T.
    Published: March 28, 2017
    Publisher:  MIT Sloan School of Management, [Cambridge, MA]

    The high cost of capital for firms conducting medical research and development (R&D) has been partly attributed to the government risk facing investors in medical innovation. This risk slows down medical innovation because investors must be... more

    Access:
    Resolving-System (kostenfrei)

    Location:
    Universitätsbibliothek Braunschweig
    Inter-library loan:
    No inter-library loan

    Location:
    Helmut-Schmidt-Universität, Universität der Bundeswehr Hamburg, Universitätsbibliothek
    Inter-library loan:
    No inter-library loan

    Location:
    ZBW - Leibniz-Informationszentrum Wirtschaft, Standort Kiel
    Signature:
    VS 67 (5194)
    Inter-library loan:
    No inter-library loan

     

    The high cost of capital for firms conducting medical research and development (R&D) has been partly attributed to the government risk facing investors in medical innovation. This risk slows down medical innovation because investors must be compensated for it. We propose new and simple financial instruments, Food and Drug Administration (FDA) hedges, to allow medical R&D investors to better share the pipeline risk associated with FDA approval with broader capital markets. Using historical FDA approval data, we discuss the pricing of FDA hedges and mechanisms under which they can be traded and estimate issuer returns from offering them. Using various unique data sources, we find that FDA approval risk has a low correlation across drug classes as well as with other assets and the overall market. We argue that this zero-beta property of scientific FDA risk could be a main source of gains from trade between issuers of FDA hedges looking for diversified investments and developers looking to offload the FDA approval risk. We offer proof of concept of the feasibility of trading this type of pipeline risk by examining related securities issued around mergers and acquisitions activity in the drug industry. Overall, our argument is that, by allowing better risk sharing between those investing in medical innovation and capital markets more generally, FDA hedges could ultimately spur medical innovation and improve the health of patients

     
    Export to reference management software   RIS file
      BibTeX file
    Content information
    Volltext (kostenfrei)
    Source: Union catalogues
    Language: English
    Media type: Book
    Format: Online
    Other identifier:
    Edition: This draft: 28 March 2017
    Series: MIT Sloan School working paper ; 5194 (17)
    MIT Sloan Research Paper ; No. 5194-17
    Subjects: Pharmakologie; Forschungskosten; Arzneimittelrecht; Genehmigung; Optionsgeschäft; Hedging; Risikomanagement; USA
    Scope: 1 Online-Ressource (circa 44 Seiten), Illustrationen
    Notes:

    FDA = Food and Drug Administration
  3. Returns to pharmaceutical innovation in the market for oral chemotherapy in response to insurance coverage expansion
    Author: Bennette, Caroline S.; Basu, Anirban; Ramsey, Scott; Helms, Zachary; Bach, Peter B.
    Published: September 2017
    Publisher:  National Bureau of Economic Research, Cambridge, MA

    Location:
    ZBW - Leibniz-Informationszentrum Wirtschaft, Standort Kiel
    Signature:
    W 1 (23842)
    Inter-library loan:
    Unlimited inter-library loan, copies and loan
    Export to reference management software   RIS file
      BibTeX file
    Source: Union catalogues
    Language: English
    Media type: Book
    Format: Print
    Series: Working paper series / National Bureau of Economic Research ; 23842
    Subjects: Krebskrankheit; Pharmakologie; Arzneimittel; Krankenversicherung; USA
    Scope: 21 Seiten, Illustrationen
    Notes:

    Erscheint auch als Online-Ausgabe
  4. Orphan Drug designations as valuable intangible assets for IPO investors in pharma-biotech companies
    Author: Gorry, Philippe; Useche, Diego
    Published: November 2017
    Publisher:  National Bureau of Economic Research, Cambridge, MA

    Location:
    ZBW - Leibniz-Informationszentrum Wirtschaft, Standort Kiel
    Signature:
    W 1 (24021)
    Inter-library loan:
    Unlimited inter-library loan, copies and loan
    Export to reference management software   RIS file
      BibTeX file
    Source: Union catalogues
    Language: English
    Media type: Book
    Format: Print
    Series: Working paper series / National Bureau of Economic Research ; 24021
    Subjects: Pharmakologie; Anreiz; Technologiepolitik; Arzneimittelrecht; Börsengang; Risikokapital; USA
    Scope: 28 Seiten, Illustrationen
    Notes:

    Erscheint auch als Online-Ausgabe
  5. Strategic interaction among governments in the provision of a global public good
    Author: Kyle, Margaret K.; Ridley, David B.; Zhang, Su
    Published: 02 November 2017
    Publisher:  Centre for Economic Policy Research, London

    Location:
    ZBW - Leibniz-Informationszentrum Wirtschaft, Standort Kiel
    Signature:
    W 32 (12419)
    Inter-library loan:
    Unlimited inter-library loan, copies and loan
    Export to reference management software   RIS file
      BibTeX file
    Source: Union catalogues
    Language: English
    Media type: Book
    Format: Print
    Series: Array ; DP 12419
    Subjects: Medizin; Pharmakologie; Forschungsfinanzierung; Amerikanisch; USA; Trittbrettfahrerverhalten; Öffentliche Güter; International; Welt
    Scope: 41 Seiten, Illustrationen
    Notes:

    Erscheint auch als Online-Ausgabe
  6. Are important innovations rewarded?
    evidence from pharmaceutical markets
    Author: Kyle, Margaret K.
    Published: 02 November 2017
    Publisher:  Centre for Economic Policy Research, London

    Location:
    ZBW - Leibniz-Informationszentrum Wirtschaft, Standort Kiel
    Signature:
    W 32 (12420)
    Inter-library loan:
    Unlimited inter-library loan, copies and loan
    Export to reference management software   RIS file
      BibTeX file
    Source: Union catalogues
    Language: English
    Media type: Book
    Format: Print
    Series: Array ; DP 12420
    Subjects: Pharmakologie; Arzneimittel; Bewertung; Einnahmen; Medizinische Behandlung; Frankreich
    Scope: 23 Seiten, Illustrationen
    Notes:

    Erscheint auch als Online-Ausgabe
  7. Research and the approval process
    the organization of persuasion
    Author: Henry, Emeric; Ottaviani, Marco
    Published: 25 March 2017
    Publisher:  Centre for Economic Policy Research, London

    Location:
    ZBW - Leibniz-Informationszentrum Wirtschaft, Standort Kiel
    Signature:
    W 32 (11939)
    Inter-library loan:
    Unlimited inter-library loan, copies and loan
    Export to reference management software   RIS file
      BibTeX file
    Source: Union catalogues
    Language: English
    Media type: Book
    Format: Print
    Series: Array ; DP 11939
    Subjects: Arzneimittel; Genehmigung; Pharmakologie; Asymmetrische Information; Interessenpolitik; Spieltheorie; Wohlfahrtsökonomik; Theorie
    Scope: 68 Seiten, Illustrationen
    Notes:

    Erscheint auch als Online-Ausgabe
  8. Sharing R&D risk in healthcare via FDA hedges
    Author: Jørring, Adam; Lo, Andrew W.; Philipson, Tomas J.; Singh, Manita; Thakor, Richard T.
    Published: April 2017
    Publisher:  National Bureau of Economic Research, Cambridge, MA

    Location:
    ZBW - Leibniz-Informationszentrum Wirtschaft, Standort Kiel
    Signature:
    W 1 (23344)
    Inter-library loan:
    Unlimited inter-library loan, copies and loan
    Export to reference management software   RIS file
      BibTeX file
    Source: Union catalogues
    Language: English
    Media type: Book
    Format: Print
    Series: Working paper series / National Bureau of Economic Research ; 23344
    Subjects: Pharmakologie; Forschungskosten; Arzneimittelrecht; Genehmigung; Optionsgeschäft; Hedging; Risikomanagement; USA
    Scope: 41, 9 Seiten, Illustrationen
    Notes:

    Erscheint auch als Online-Ausgabe

    FDA = Food and Drug Administration
  9. Innovationseffekte der industriellen Gesundheitswirtschaft
    das Beispiel Novartis
    Author: Reiß, Thomas; Bratan, Tanja; Aichinger, Heike; Schmoch, Ulrich
    Published: [2017]; © 2017
    Publisher:  Fraunhofer Verlag, Stuttgart

    Location:
    Sächsische Landesbibliothek - Staats- und Universitätsbibliothek Dresden
    Inter-library loan:
    Unlimited inter-library loan, copies and loan

    Location:
    Universitäts- und Landesbibliothek Sachsen-Anhalt / Zentrale
    Signature:
    RB 10732 115
    Inter-library loan:
    Unlimited inter-library loan, copies and loan

    Location:
    Staats- und Universitätsbibliothek Hamburg Carl von Ossietzky
    Signature:
    QX 700 R378 82316
    Inter-library loan:
    No inter-library loan

    Location:
    Technische Informationsbibliothek (TIB) / Leibniz-Informationszentrum Technik und Naturwissenschaften und Universitätsbibliothek
    Signature:
    F 17 B 2057
    Inter-library loan:
    Unlimited inter-library loan, copies and loan

    Location:
    ZBW - Leibniz-Informationszentrum Wirtschaft, Standort Kiel
    Signature:
    B 408134
    Inter-library loan:
    Unlimited inter-library loan, copies and loan

    Location:
    Württembergische Landesbibliothek
    Signature:
    67C/662
    Inter-library loan:
    Unlimited inter-library loan, copies and loan
    Export to reference management software   RIS file
      BibTeX file
    Content information
    Source: Union catalogues
    Language: German
    Media type: Book
    Format: Print
    ISBN: 9783839612156; 3839612152
    Other identifier:
    9783839612156
    fhg-isi_198
    RVK Categories: QX 700 ; VX 5500
    Series: ISI-Schriftenreihe "Innovationspotenziale"
    Subjects: Pharmaindustrie; Pharmakologie; Industrieforschung; Innovationsdiffusion; Wissenstransfer; Multinationales Unternehmen; Schweizerisch; Standortfaktor; Deutschland; Innovationsfußabdruck
    Scope: viii, 125 Seiten, Diagramme, 23.2 cm x 16.5 cm